Related Experiment Video

Updated: Aug 12, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Reducing cardiovascular disease in patients with diabetes mellitus

Theodore Mazzone1

  • 1Section of Diabetes and Metabolism, University of Illinois at Chicago, Chicago, IL 60612, USA. tmazzone@uic.edu

Current Opinion in Cardiology
|June 16, 2005
PubMed

Insights

Patients with diabetes face high cardiovascular risk due to coronary artery disease. Managing hypertension and hyperlipidemia is crucial, though the role of glucose control requires further research.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Patients with diabetes mellitus are at increased risk for cardiovascular disease (CVD) events.
  • This heightened risk stems from elevated rates of myocardial infarction (MI), prevalent subclinical coronary artery disease, and poorer prognoses post-MI.

Purpose of the Study:

  • To review current strategies for managing cardiovascular risk factors in patients with diabetes.
  • To highlight the established benefits of managing hypertension and hyperlipidemia.
  • To discuss the evolving understanding of glucose control's impact on CVD risk.

Main Methods:

  • Review of existing clinical trial data and epidemiological studies.
  • Analysis of treatment guidelines for hypertension and hyperlipidemia in diabetic populations.
  • Evaluation of evidence regarding glucose-lowering therapies and cardiovascular outcomes.

Main Results:

  • Aggressive management of hypertension and hyperlipidemia demonstrably reduces cardiovascular events.
  • Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may offer advantages in hypertension management.
  • Statins are the primary agents for lipid management; combination therapy efficacy needs further validation.

Conclusions:

  • The precise role of glycemic control in mitigating cardiovascular risk in diabetes remains uncertain.
  • Strong associations exist between glycemia markers and CVD risk, even in non-diabetic individuals.
  • New therapeutic strategies targeting cardiovascular event reduction in diabetes are under active investigation.
Abstract

More Related Videos

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy05:06

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...